{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T10:14:46Z","timestamp":1766225686776,"version":"3.48.0"},"reference-count":59,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multiple sclerosis (MS) is a major demyelinating disorder that affects the central nervous system. A growing body of evidence has revealed the involvement of coagulation pathway in the pathogenesis of MS. However, the causal association between coagulation factors and MS is still unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A two-sample Mendelian randomization (MR) analysis was conducted. Genetic variants for plasma coagulation factors were identified as instrumental variables. Summary-level statistics for MS were collected from a large-scale genome-wide association study, including 47,429 cases and 68,374 controls. Primary MR analysis was performed using the inverse-variance weighting (IVW) approach. False discovery rate (FDR)-adjusted method was applied to adjust for multiple testing. MR-Egger, weighted median, simple mode, weighted mode, and MR-pleiotropy residual sum and outlier (MR-PRESSO) methods were used as sensitivity analysis approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A causal effect of higher plasma tissue factor (TF) levels on the risk of MS onset was identified using IVW method (OR: 1.215, 95% CI 1.108\u20131.333,\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001,\n                      <jats:italic>P<\/jats:italic>\n                      <jats:sub>FDR<\/jats:sub>\n                      &lt; 0.001). Complementary analysis using weighted median (OR: 1.262, 95% CI: 1.119\u20131.423,\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001), weighted mode (OR: 1.238, 95% CI: 1.100\u20131.394,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.012), and MR-PRESSO (OR: 1.215, 95% CI: 1.125\u20131.313,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.003) methods yielded consistent results. Null associations were found for other plasma coagulation factors with MS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The study demonstrates a suggestive association between TF and MS. Increasing plasma TF was associated with an increase in MS risk. TF should be a promising biomarker and new target for MS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/tnsci-2025-0378","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T09:55:51Z","timestamp":1755338151000},"source":"Crossref","is-referenced-by-count":0,"title":["Plasma tissue factor as a promising marker in multiple sclerosis: Evidence from a two-sample Mendelian randomization study"],"prefix":"10.1515","volume":"16","author":[{"given":"Rui","family":"Pan","sequence":"first","affiliation":[{"name":"School of Nursing, Huizhou Health Sciences Polytechnic , Huizhou , Guangdong , P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiqi","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Laboratory, Huizhou Health Sciences Polytechnic , Huizhou , Guangdong , P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqi","family":"Li","sequence":"additional","affiliation":[{"name":"School of Nursing, Huizhou Health Sciences Polytechnic , Huizhou , Guangdong , P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qizhi","family":"Xie","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Laboratory, Huizhou Health Sciences Polytechnic , Huizhou , Guangdong , P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihua","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Nursing, Huizhou Health Sciences Polytechnic , Huizhou , Guangdong , P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Li","sequence":"additional","affiliation":[{"name":"School of Nursing, Huizhou Health Sciences Polytechnic , Huizhou , Guangdong , P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Shi","sequence":"additional","affiliation":[{"name":"The Affiliated Brain Hospital, Guangzhou Medical University , No. 36, Ming Xin Road , Guangzhou , Guangdong , P. R. China"},{"name":"Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders , Guangzhou , Guangdong , P. R. China"},{"name":"Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University , Guangzhou , P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"key":"2025122010110640728_j_tnsci-2025-0378_ref_001","doi-asserted-by":"crossref","unstructured":"Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet. 2018;391(10130):1622\u201336.","DOI":"10.1016\/S0140-6736(18)30481-1"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_002","doi-asserted-by":"crossref","unstructured":"Ribbert H. Ueber multiple sclerose des Gehirns und R\u00fcckenmarks. Virchows Archiv A. Pathological Anatomy and Histology. 1882;90:243\u201360.","DOI":"10.1515\/9783112388167-010"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_003","doi-asserted-by":"crossref","unstructured":"Putnam TJ. Evidences of vascular occlusion in multiple sclerosis and \u201cEncephalomyelitis\u201d. Arch Neurol Psychiatry. 1937;37(6):1298\u2013321.","DOI":"10.1001\/archneurpsyc.1937.02260180078006"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_004","doi-asserted-by":"crossref","unstructured":"Putnam TJ. Lesions of encephalomyelitis and multiple sclerosis: venous thrombosis as the primary alteration. JAMA-J Am Med Assoc. 1937;108:1477\u201380.","DOI":"10.1001\/jama.1937.02780180001001"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_005","doi-asserted-by":"crossref","unstructured":"Roshanisefat H, Bahmanyar S, Hillert J, Olsson T, Montgomery S. Multiple sclerosis clinical course and cardiovascular disease risk \u2013 Swedish cohort study. Eur J Neurol. 2014;21(11):1353\u201388.","DOI":"10.1111\/ene.12518"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_006","doi-asserted-by":"crossref","unstructured":"Marrie RA, Reider N, Cohen J, Stuve O, Trojano M, Cutter G, et al. A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis. Mult Scler J. 2015;21(3):318\u201331.","DOI":"10.1177\/1352458514564485"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_007","doi-asserted-by":"crossref","unstructured":"Plantone D, Inglese M, Salvetti M, Koudriavtseva T. A perspective of coagulation dysfunction in multiple sclerosis and in experimental allergic encephalomyelitis. Front Neurol. 2018;9:1175.","DOI":"10.3389\/fneur.2018.01175"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_008","doi-asserted-by":"crossref","unstructured":"Abbadessa G, Lavorgna L, Treaba CA, Bonavita S, Mainero C. Hemostatic factors in the pathogenesis of neuroinflammation in multiple sclerosis. Mult Scler J. 2022;28(12):1834\u201342.","DOI":"10.1177\/13524585211039111"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_009","doi-asserted-by":"crossref","unstructured":"Gobel K, Pankratz S, Asaridou CM, Herrmann AM, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626.","DOI":"10.1038\/ncomms11626"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_010","doi-asserted-by":"crossref","unstructured":"Yates RL, Esiri MM, Palace J, Jacobs B, Perera R, DeLuca GC. Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex. Ann Neurol. 2017;82(2):259\u201370.","DOI":"10.1002\/ana.24997"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_011","doi-asserted-by":"crossref","unstructured":"Davalos D, Ryu JK, Merlini M, Baeten KM, Le Moan N, Petersen MA, et al. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun. 2012;3:1227.","DOI":"10.1038\/ncomms2230"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_012","doi-asserted-by":"crossref","unstructured":"Davalos D, Baeten KM, Whitney MA, Mullins ES, Friedman B, Olson ES, et al. Early detection of thrombin activity in neuroinflammatory disease. Ann Neurol. 2014;75(2):303\u20138.","DOI":"10.1002\/ana.24078"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_013","doi-asserted-by":"crossref","unstructured":"PERSSON I. Variations in the plasma fibrinogen during the course of multiple sclerosis. AMA Arch Neurol Psychiatry. 1955;74(1):17\u201330.","DOI":"10.1001\/archneurpsyc.1955.02330130019004"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_014","doi-asserted-by":"crossref","unstructured":"Gobel K, Kraft P, Pankratz S, Gross CC, Korsukewitz C, Kwiecien R, et al. Prothrombin and factor X are elevated in multiple sclerosis patients. Ann Neurol. 2016;80(6):946\u201351.","DOI":"10.1002\/ana.24807"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_015","doi-asserted-by":"crossref","unstructured":"Ziliotto N, Baroni M, Straudi S, Manfredini F, Mari R, Menegatti E, et al. Coagulation factor XII levels and intrinsic thrombin generation in multiple sclerosis. Front Neurol. 2018;9:245.","DOI":"10.3389\/fneur.2018.00245"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_016","doi-asserted-by":"crossref","unstructured":"Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133\u201363.","DOI":"10.1002\/sim.3034"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_017","doi-asserted-by":"crossref","unstructured":"Verduijn M, Siegerink B, Jager KJ, Zoccali C, Dekker FW. Mendelian randomization: use of genetics to enable causal inference in observational studies. Nephrol Dial Transpl. 2010;25(5):1394\u20138.","DOI":"10.1093\/ndt\/gfq098"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_018","doi-asserted-by":"crossref","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA. 2021;326:1614\u201321.","DOI":"10.1001\/jama.2021.18236"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_019","doi-asserted-by":"crossref","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA-J Am Med Assoc. 2017;318(19):1925\u20136.","DOI":"10.1001\/jama.2017.17219"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_020","doi-asserted-by":"crossref","unstructured":"Folkersen L, Gustafsson S, Wang Q, Hansen DH, Hedman AK, Schork A, et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat Metab. 2020;2(10):1135\u201348.","DOI":"10.1038\/s42255-020-00287-2"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_021","doi-asserted-by":"crossref","unstructured":"Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558(7708):73\u20139.","DOI":"10.1038\/s41586-018-0175-2"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_022","unstructured":"Patsopoulos NA, Baranzini SE, Santaniello A, Shoostari P, Cotsapas C, Wong G, et al. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science. 2019;365:6460."},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_023","doi-asserted-by":"crossref","unstructured":"Pietzner M, Wheeler E, Carrasco-Zanini J, Raffler J, Kerrison ND, Oerton E, et al. Genetic architecture of host proteins involved in SARS-CoV-2 infection. Nat Commun. 2020;11(1):6397.","DOI":"10.1038\/s41467-020-19996-z"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_024","doi-asserted-by":"crossref","unstructured":"Patsopoulos NA, Bayer Pharma MS Genetics Working Group, ANZgene Consortium, International Multiple Sclerosis Genetics Consortium, Esposito F, Reischl J, et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol. 2011;70(6):897\u2013912.","DOI":"10.1002\/ana.22609"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_025","doi-asserted-by":"crossref","unstructured":"International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer CCA, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011;476(7359):214\u20139.","DOI":"10.1038\/nature10251"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_026","doi-asserted-by":"crossref","unstructured":"Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13(3):227\u201331.","DOI":"10.1002\/ana.410130302"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_027","doi-asserted-by":"crossref","unstructured":"McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121\u20137.","DOI":"10.1002\/ana.1032"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_028","doi-asserted-by":"crossref","unstructured":"Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42(5):1497\u2013501.","DOI":"10.1093\/ije\/dyt179"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_029","doi-asserted-by":"crossref","unstructured":"Staley JR, Blackshaw J, Kamat MA, Ellis S, Surendran P, Sun BB, et al. PhenoScanner: a database of human genotype\u2013phenotype associations. Bioinformatics. 2016;32(20):3207\u20139.","DOI":"10.1093\/bioinformatics\/btw373"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_030","doi-asserted-by":"crossref","unstructured":"Burgess S, Davey SG, Davies NM, Dudbridge F, Gill D, Glymour MM, et al. Guidelines for performing Mendelian randomization investigations: update for summer. 2023. Wellcome Open Res. 2019;4:186.","DOI":"10.12688\/wellcomeopenres.15555.1"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_031","doi-asserted-by":"crossref","unstructured":"Bowden J, Davey SG, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314.","DOI":"10.1002\/gepi.21965"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_032","doi-asserted-by":"crossref","unstructured":"Hartwig FP, Davey SG, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985\u201398.","DOI":"10.1093\/ije\/dyx102"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_033","doi-asserted-by":"crossref","unstructured":"Cohen JF, Chalumeau M, Cohen R, Korevaar DA, Khoshnood B, Bossuyt PM. Cochran\u2019s Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracy. J Clin Epidemiol. 2015;68(3):299\u2013306.","DOI":"10.1016\/j.jclinepi.2014.09.005"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_034","doi-asserted-by":"crossref","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138.","DOI":"10.1038\/s41588-018-0099-7"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_035","doi-asserted-by":"crossref","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.","DOI":"10.7554\/eLife.34408"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_036","doi-asserted-by":"crossref","unstructured":"Versteeg HH, Heemskerk JW, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev. 2013;93(1):327\u201358.","DOI":"10.1152\/physrev.00016.2011"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_037","doi-asserted-by":"crossref","unstructured":"Koudriavtseva T, Lorenzano S, Cellerino M, Truglio M, Fiorelli M, Lapucci C, et al. Tissue factor as a potential coagulative\/vascular marker in relapsing-remitting multiple sclerosis. Front Immunol. 2023;14:1226616.","DOI":"10.3389\/fimmu.2023.1226616"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_038","doi-asserted-by":"crossref","unstructured":"Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013;13(1):34\u201345.","DOI":"10.1038\/nri3345"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_039","doi-asserted-by":"crossref","unstructured":"Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, et al. Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity. PLoS One. 2017;12(2):e0172558.","DOI":"10.1371\/journal.pone.0172558"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_040","doi-asserted-by":"crossref","unstructured":"De Palma R, Cirillo P, Ciccarelli G, Barra G, Conte S, Pellegrino G, et al. Expression of functional tissue factor in activated T-lymphocytes in vitro and in vivo: a possible contribution of immunity to thrombosis? Int J Cardiol. 2016;218:188\u201395.","DOI":"10.1016\/j.ijcard.2016.04.177"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_041","doi-asserted-by":"crossref","unstructured":"Zelaya H, Rothmeier AS, Ruf W. Tissue factor at the crossroad of coagulation and cell signaling. J Thromb Haemost. 2018;16(10):1941\u201352.","DOI":"10.1111\/jth.14246"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_042","doi-asserted-by":"crossref","unstructured":"Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med. 2003;9(4):458\u201362.","DOI":"10.1038\/nm841"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_043","doi-asserted-by":"crossref","unstructured":"Mechelli R, Umeton R, Policano C, Annibali V, Coarelli G, Ricigliano VA, et al. A \u201ccandidate-interactome\u201d aggregate analysis of genome-wide association data in multiple sclerosis. PLoS One. 2013;8(5):e63300.","DOI":"10.1371\/journal.pone.0063300"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_044","doi-asserted-by":"crossref","unstructured":"Saberi A, Akhondzadeh S, Kazemi S. Infectious agents and different course of multiple sclerosis: a systematic review. Acta Neurol Belg. 2018;118(3):361\u201377.","DOI":"10.1007\/s13760-018-0976-y"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_045","doi-asserted-by":"crossref","unstructured":"Boesen MS, Koch-Henriksen N, Thygesen LC, Eriksson F, Greisen G, Born AP, et al. Infections seem to be more frequent before onset of pediatric multiple sclerosis: a Danish nationwide nested case-control study. Mult Scler J. 2019;25(6):783\u201391.","DOI":"10.1177\/1352458518771871"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_046","doi-asserted-by":"crossref","unstructured":"Antoniak S. The coagulation system in host defense. Res Pract Thromb Haemost. 2018;2(3):549\u20137.","DOI":"10.1002\/rth2.12109"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_047","doi-asserted-by":"crossref","unstructured":"Kirk J, Zhou AL. Viral infection at the blood\u2013brain barrier in multiple sclerosis: an ultrastructural study of tissues from a UK Regional Brain Bank. Mult Scler J. 1996;1(4):242\u201352.","DOI":"10.1177\/135245859600100410"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_048","doi-asserted-by":"crossref","unstructured":"Alvarez JI, Saint-Laurent O, Godschalk A, Terouz S, Briels C, Larouche S, et al. Focal disturbances in the blood\u2013brain barrier are associated with formation of neuroinflammatory lesions. Neurobiol Dis. 2015;74:14\u201324.","DOI":"10.1016\/j.nbd.2014.09.016"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_049","doi-asserted-by":"crossref","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14(3):133\u201350.","DOI":"10.1038\/nrneurol.2017.188"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_050","doi-asserted-by":"crossref","unstructured":"Eddleston M, de la Torre JC, Oldstone MB, Loskutoff DJ, Edgington TS, Mackman N. Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis. J Clin Invest. 1993;92(1):349\u201358.","DOI":"10.1172\/JCI116573"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_051","doi-asserted-by":"crossref","unstructured":"Wang S, Reeves B, Pawlinski R. Astrocyte tissue factor controls CNS hemostasis and autoimmune inflammation. Thromb Res. 2016;141(Suppl 2):S65\u20137.","DOI":"10.1016\/S0049-3848(16)30369-3"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_052","doi-asserted-by":"crossref","unstructured":"De Luca C, Virtuoso A, Maggio N, Papa M. Neuro-coagulopathy: blood coagulation factors in central nervous system diseases. Int J Mol Sci. 2017;18(10):2128.","DOI":"10.3390\/ijms18102128"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_053","doi-asserted-by":"crossref","unstructured":"Ryu JK, Petersen MA, Murray SG, Baeten KM, Meyer-Franke A, Chan JP, et al. Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation. Nat Commun. 2015;6:8164.","DOI":"10.1038\/ncomms9164"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_054","doi-asserted-by":"crossref","unstructured":"Petersen MA, Ryu JK, Chang KJ, Etxeberria A, Bardehle S, Mendiola AS, et al. Fibrinogen activates BMP signaling in oligodendrocyte progenitor cells and inhibits remyelination after vascular damage. Neuron. 2017;96(5):1003\u201312.","DOI":"10.1016\/j.neuron.2017.10.008"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_055","doi-asserted-by":"crossref","unstructured":"Antoniak S, Mackman N. Multiple roles of the coagulation protease cascade during virus infection. Blood. 2014;123(17):2605\u201313.","DOI":"10.1182\/blood-2013-09-526277"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_056","doi-asserted-by":"crossref","unstructured":"Han MH, Hwang SI, Roy DB, Lundgren DH, Price JV, Ousman SS, et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature. 2008;451(7182):1076\u201381.","DOI":"10.1038\/nature06559"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_057","doi-asserted-by":"crossref","unstructured":"Ziliotto N, Bernardi F, Jakimovski D, Baroni M, Marchetti G, Bergsland N, et al. Hemostasis biomarkers in multiple sclerosis. Eur J Neurol. 2018;25(9):1169\u201376.","DOI":"10.1111\/ene.13681"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_058","doi-asserted-by":"crossref","unstructured":"Koudriavtseva T, Mainero C. Neuroinflammation, neurodegeneration and regeneration in multiple sclerosis: intercorrelated manifestations of the immune response. Neural Regen Res. 2016;11(11):1727\u201330.","DOI":"10.4103\/1673-5374.194804"},{"key":"2025122010110640728_j_tnsci-2025-0378_ref_059","doi-asserted-by":"crossref","unstructured":"Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol. 2012;34(1):43\u201362.","DOI":"10.1007\/s00281-011-0290-8"}],"container-title":["Translational Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/tnsci-2025-0378\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/tnsci-2025-0378\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T10:14:04Z","timestamp":1766225644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/tnsci-2025-0378\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,4,24]]},"published-print":{"date-parts":[[2025,4,24]]}},"alternative-id":["10.1515\/tnsci-2025-0378"],"URL":"https:\/\/doi.org\/10.1515\/tnsci-2025-0378","relation":{},"ISSN":["2081-6936"],"issn-type":[{"type":"electronic","value":"2081-6936"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"article-number":"20250378"}}